Главная
Рынки
Графики и идеи
Алготрейдинг
Новости
Store
Брокеры
Скачать
Экономический календарь
Торговые сигналы
Вебтерминал
Нажмите
/
для поиска: @user, $symbol, ...
Поиск
Вход
Создать аккаунт
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RCUS
#1597
Arcus Biosciences, Inc.
20.3
8
+4.57%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
Годовой диапазон
Дневное изменение
+4.57%
Месячное изменение
-12.53%
6-месячное изменение
+92.26%
Годовое изменение
+96.53%
Предыдущее закрытие
19.4
9
Open
20.1
5
Bid
Ask
Low
20.0
7
High
20.4
4
Объем
601
Рынки
Рынок акций США
Здравоохранение
RCUS
Open full chart
Financials
Overview
Отчетность
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
91.51 M
105.84 M
105.89 M
106.43 M
107.97 M
125.35 M
—
Valuation ratios
Enterprise value
1.2 B
1.43 B
639.2 M
618.35 M
1.23 B
2.77 B
5.25 B
Price to earnings ratio
-4.85
-4.74
-1.86
-2.54
-3.91
-7.24
-15.54
Price to sales ratio
5.01
5.2
5.14
3.13
5.86
10.36
24.5
Price to cash flow ratio
7.8
7.89
2.45
2.38
2.95
5.31
13.1
Price to book ratio
0.55
2.77
0.33
0.37
0.68
4.06
5.43
Enterprise value to EBITDA ratio
-3.49
-4.02
-1.39
-1.73
-3.15
-6.93
-13.2
Profitability ratios
Return on assets %
0.07
0.08
0.1
0
0.14
0.09
0.33
Return on equity %
0.16
0.19
0.21
0
0.31
0.17
0.69
Return on invested capital %
133.76
133.41
165.7
—
198.95
160.28
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
218.75
396.15
435.71
5
546.15
345.45
1 332.32
EBITDA margin %
-231.25
-419.23
-450
-6.88
-557.69
-354.55
-1 369.11
Net margin %
191.67
361.54
400
0
519.23
321.21
1 240.44
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
5.24
4.5
5.37
4.5
3.65
4.36
17.88
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.04
0.02
0.02
0.14
0.03
0.03
0.22
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.04
0.04
0.04
0.09
0.1
0.09
0.32
Long term debt to total equity ratio
0.08
0.1
0.09
0.18
0.22
0.16
0.65
Per share metrics
Operating cash flow per share
-0.28
1.11
1.34
1.25
0.91
1.12
4.62
EBIT per share
-1.15
-1.14
-1.24
-0.08
-1.33
-1.06
-3.71
EBITDA per share
-1.21
-1.21
-1.28
-0.1
-1.36
-1.09
-3.83
Total debt per share
—
—
—
—
—
—
—
Cash per share
11.91
10.85
10.13
8.55
7.8
9.13
35.62
Net current asset value per share
12.33
11.28
10.48
8.88
8.05
9.38
36.78
Tangible book value per share
6.18
5.38
5.4
5.15
4.09
5.88
20.52
Working capital per share
9.98
8.77
8.53
6.91
5.84
7.23
28.5
Book value per share
6.18
5.38
5.4
5.15
4.09
5.88
20.52
Новости
Arcus Biosciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NYSE:RCUS) 2026-02-27
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline
Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
Arcus Biosciences, Inc. (RCUS) Q4 2025 Earnings Call Transcript
Презентация Arcus 2025: данные по касдатифану укрепляются
Arcus 2025 presentation: casdatifan data strengthens, I&I pipeline emerges
Arcus Biosciences earnings beat by $0.21, revenue fell short of estimates
Arcus Biosciences в центре внимания: результаты испытания препарата
Arcus Biosciences in spotlight: Kidney drug trial results at stake